YSB INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.1 HKD | -0.61% |
|
-1.82% | -1.70% |
| Apr. 25 | YSB Trustee Buys Back Shares For Incentive Scheme | MT |
| Apr. 19 | YSB Widens Loss by 114% in 2023 | MT |
| Sales 2022 | 14.27B 1.97B 15.42B | Sales 2023 | 16.97B 2.34B 18.33B | Capitalization | 4.8B 662M 5.18B |
|---|---|---|---|---|---|
| Net income 2022 | -1.49B -206M -1.61B | Net income 2023 | -3.19B -440M -3.44B | EV / Sales 2022 * | - |
| Net cash position 2022 | 1.69B 233M 1.82B | Net cash position 2023 | 1.62B 224M 1.75B | EV / Sales 2023 | 0.19 x |
| P/E ratio 2022 * |
-
| P/E ratio 2023 |
-0.91
x | Employees | 6,306 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 29.77% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.61% | ||
| 1 week | -1.82% | ||
| Current month | -0.25% | ||
| 1 month | -1.94% | ||
| 3 months | +19.82% | ||
| 6 months | -81.59% | ||
| Current year | -1.70% |
1 week
7.88
8.38
1 month
7.678.99
Current year
5.9110.98
1 year
5.9164.50
3 years
5.9164.50
5 years
5.9164.50
10 years
5.9164.50
| Managers | Title | Age | Since |
|---|---|---|---|
Bu Zhen Zhang
CEO | Chief Executive Officer | 49 | 14-12-31 |
Fei Chen
DFI | Director of Finance/CFO | 40 | 22-03-31 |
Zhuo Qi Chen
CTO | Chief Tech/Sci/R&D Officer | 45 | 18-08-26 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Han Hui Sun
BRD | Director/Board Member | 50 | 23-06-14 |
Rong Shao
BRD | Director/Board Member | 62 | 23-06-14 |
Bu Zhen Zhang
CEO | Chief Executive Officer | 49 | 14-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 8.1 | -0.61% | 999 000 |
| 24-04-29 | 8.15 | +1.37% | 1,305,400 |
| 24-04-26 | 8.04 | +1.39% | 1,332,600 |
| 24-04-25 | 7.93 | -3.29% | 1,599,200 |
| 24-04-24 | 8.2 | -0.61% | 1,907,200 |
Delayed Quote Hong Kong S.E., April 30, 2024 at 04:08 am EDT
More quotes
YSB Inc is an investment holding company mainly engaged in the provision of wholesale and retail of pharmaceuticals and healthcare products, as well as the provision of platform business services. The Company is mainly engaged in the wholesale and retail of pharmaceuticals and healthcare products on offline or online platforms. The Company provides an online platform for pharmaceutical distributors to sell their pharmaceuticals and healthcare products. The Company also provides software-as-a-service (SaaS) solutions for pharmacies, provides medical testing services for primary medical institutions, sells smart unmanned pharmaceutical booth to third-party pharmacies, as well as provides maintenance and technical support services in relation to the smart unmanned pharmaceutical booth to third-party pharmacies. The Company principally conducts its businesses in the domestic market.
Sector
Pharmaceuticals
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -1.70% | 667M | |
| +15.79% | 70.45B | |
| +2.09% | 25.03B | |
| -2.98% | 8.05B | |
| +7.95% | 8.29B | |
| -20.48% | 7.97B | |
| +15.26% | 4.25B | |
| -1.24% | 4.04B | |
| -3.02% | 3.86B | |
| +21.10% | 3.61B |
- Stock Market
- Equities
- 9885 Stock
